K-numberK251038
Device nameDigital Radiographic Imaging Acquisition Software - DR (RiasDR)
ApplicantShen Zhen Cambridge-Hit Co., Ltd.
Product codeLLZ
Device classClass II
Decision dateAug 6, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

RiaspDR is radiographic imaging acquisition software that directly controls and acquires general radiographic images of human anatomy (excluding fluoroscopic, angiographic, dental, and mammographic applications) from the Mars1417X digital X-ray detector. The software performs image viewing, searching, storage, annotation, measurement, and processing while complying with DICOM standards and interfacing with PACS systems.

Technological characteristics

The subject device includes wireless connectivity via TCP/IP or WiFi for detector communication, whereas the predicate device (Econsole1) did not have wireless capability. Both devices support the same core functions: image viewing, search, storage, annotation, measurement, and processing. Both use digital X-ray detectors, are DICOM 3.0 compatible, and fall under the same regulatory classification and product code (LLZ, 21 CFR 892.2050).

Test standards cited

Software Verification and Validation testing was performed in accordance with FDA guidance on Content of Premarket Submissions for Device Software Functions (June 14, 2023), Cybersecurity in Medical Devices: Quality System Considerations and Content of Premarket Submissions (September 27, 2023), and the Digital Imaging and Communications in Medicine (DICOM) Set standard.

Substantial equivalence argument

The device is substantially equivalent because it shares the same regulatory classification, product code, intended use (general radiographic imaging), and core software functions with the predicate Econsole1 device. Both devices perform identical image management and processing operations on digital X-ray detector data and maintain DICOM 3.0 compatibility. The addition of wireless connectivity represents a minor feature enhancement that does not alter the fundamental intended use or safety profile, and verification testing confirmed the device meets predetermined acceptance criteria consistent with the predicate's performance.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →